Virtual vs. real: which exposure therapy works best for agoraphobia?
NCT ID NCT06514495
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares two types of exposure therapy for agoraphobia: real-life exposure and virtual reality exposure. Researchers will measure how these therapies affect body awareness and stress-related chemicals. The goal is to understand why therapy works and how to improve it for people with agoraphobia, panic disorder, or social anxiety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cognitive behavioral psychotherapy with exposure (in vivo or virtual reality)
- What this could lead to
- If successful, this could help tailor exposure therapy for agoraphobia by identifying which method works best and why.
- What could go wrong
- This is a small, early-stage study (68 participants) focused on understanding mechanisms, not proving a new treatment. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGORAPHOBIA; PANIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Center
RECRUITINGMainz, 55122, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can rewiring fear expectations stop anxiety from coming back?
- Can an AI coach help therapists treat depression and anxiety online?
- Can a unified therapy tame both addiction and emotional disorders?
- Can online therapy or parent coaching ease childhood anxiety? a head-to-head trial aims to find out.
- Can learning Self-Compassion quiet anxiety and depression?
- A common antidepressant may tame anxiety in kids with autism and ADHD — a trial puts it to the test